Drug Interaction Study With Dabigatran Etexilate and Dronedarone in Healthy Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess the relative bioavailability of a single dose of
dabigatran after concomitant multiple oral administration of dronedarone with the aim to
investigate whether and to what extent the P-gp inhibitor dronedarone affects pharmacokinetic
parameters of dabigatran when administered to healthy subjects